Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-002651
Filing Date
2023-01-13
Accepted
2023-01-13 11:47:42
Documents
11
Period of Report
2023-01-13

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea171609-6k_canfitebio.htm 6-K 27877
2 OPINION OF DORON TIKOTZKY KANTOR GUTMAN, NASS & AMIT GROSS ea171609ex5-1_canfitebio.htm EX-5.1 36335
3 OPINION OF GREENBERG TRAURIG, LLP ea171609ex5-2_canfitebio.htm EX-5.2 11683
4 FORM OF REGISTERED DIRECT OFFERING SECURITIES PURCHASE AGREEMENT, DATED JANUARY ea171609ex10-1_canfitebio.htm EX-10.1 216973
5 FORM OF PIPE SECURITIES PURCHASE AGREEMENT, DATED JANUARY 11, 2023 ea171609ex10-2_canfitebio.htm EX-10.2 209170
6 FORM OF REGISTERED DIRECT PRE-FUNDED WARRANT ea171609ex10-3_canfitebio.htm EX-10.3 100181
7 FORM OF SERIES A AND SERIES B WARRANT ea171609ex10-4_canfitebio.htm EX-10.4 109743
8 FORM OF PRIVATE PLACEMENT PRE-FUNDED WARRANT ea171609ex10-5_canfitebio.htm EX-10.5 103583
9 FORM OF REGISTRATION RIGHTS AGREEMENT, DATED JANUARY 11, 2023 ea171609ex10-6_canfitebio.htm EX-10.6 128303
10 GRAPHIC ex5-1_001.jpg GRAPHIC 5269
11 GRAPHIC ex5-2_001.jpg GRAPHIC 10371
  Complete submission text file 0001213900-23-002651.txt   966737
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 23527851
SIC: 2834 Pharmaceutical Preparations